Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Knoxville › NPI 1932200664
Physician

Southeastern Retina Associates, P.C.

Southeastern Retina Associates, P.C. was paid $1.91M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 52% of everything it billed.

33Billing provider infoSOUTHEASTERN RETINA ASSOCIATES, P.C.
KNOXVILLE, TN 37909
33aNPI1932200664assigned 09/26/2006
33bProvider typeOphthalmology Physician
28Total paid$1.91M
24GClaims103,213
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ophthalmology Physician providers in Tennessee

Rank by total paid#6 of 114
Median peer was paid$15K
This provider vs. median130×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201811,877$259K
201914,030$271K
202011,921$264K
202117,072$283K
202218,375$270K
202315,267$312K
2024incomplete14,671$253K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
67028 Intravitreal injection of a pharmacologic agent 52% 24,994 18,025 $992K
92134 19% 39,917 30,289 $356K
J9035 Injection, bevacizumab, 10 mg 10.0% 20,390 12,217 $191K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.8% 10,677 7,722 $169K
J2778 Injection, ranibizumab, 0.1 mg 2.7% 454 281 $52K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 1.9% 2,042 1,521 $36K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.4% 1,168 926 $27K
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg 1.1% 505 175 $21K
92250 <1% 1,196 960 $18K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 343 282 $14K
92226 <1% 347 123 $13K
99233 Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m <1% 193 106 $9K
5 more codes
92201 <1% 443 $6K
J0178 Injection, aflibercept, 1 mg <1% 30 $5K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 451 $3K
99223 Prolong inpt eval add15 m <1% 17 $1K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 46 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLAVERGHETTA, ANDREW (CEO)
Same official

Other billing entities under LAVERGHETTA, ANDREW

Full network →
ProviderLocationPaid
Southeastern Retina Associates, P.C.Kingsport, TN$1.98M
Southeastern Retina Associates, P.C.Hixson, TN$327K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.